ABO-incompatible renal transplantation: From saline flushes to antigen-specific immunoadsorption-Tools to overcome the barrier

Korean Journal of Hematology

Volumn 46, Issue 3, 2011, Pages 164-168

  Schiffer, Mario ^a   Kielstein, Jan T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Graft loss; Graft survival; Preconditioning; Rejection

Indexed keywords

EID: 84859836835     PISSN: 17387949     EISSN: 20929129     Source Type: Journal    
DOI: 10.5045/kjh.2011.46.3.164     Document Type: Review

References (40)

1. Kantha SS. The blood revolution initiated by the famous footnote of Karl Landsteiner's 1900 paper. Ceylon Med J 1995;40:123-5.
2. Yamamoto F, McNeill PD, Hakomori S. Genomic organization of human histo-blood group ABO genes. Glycobiology 1995;5:51-8.
3. Reed E, Moore BP. A new variant of blood group A. Vox Sang 1964;9:363-6.
4. Sturgeon P, Moore BP, Weiner W. Notations for two weak a variants: AEND and AEL. Vox Sang 1964;9:214-5.
5. Economidou J, Hughes-Jones NC, Gardner B. Quantitative measurements concerning A and B antigen sites. Vox Sang 1967;12:321-8.
6. Andersson M, Carlin N, Leontein K, Lindquist U, Slettengren K. Structural studies of the O-antigenic polysaccharide of Escherichia coli O86, which possesses blood-group B activity. Carbohydr Res 1989;185:211-23.
7. Hardy RR, Hayakawa K. CD5 B cells, a fetal B cell lineage. Adv Immunol 1994;55:297-339.
8. Hanto DW, Brunt EM, Goss JA, Cole BR. Accelerated acute rejection of an A2 renal allograft in an O recipient: association with an increase in anti-A2 antibodies. Transplantation 1993;56: 1580-3.
9. Ruggeri ZM. von Willebrand factor. J Clin Invest 1997;99:559-64.
10. Sodetz JM, Paulson JC, McKee PA. Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human Factor VIII/von Willebrand factor. J Biol Chem 1979;254:10754-60.
11. Matsui T, Shimoyama T, Matsumoto M, et al. ABO blood group antigens on human plasma von Willebrand factor after ABOmismatched bone marrow transplantation. Blood 1999;94:2895-900.
12. Hume DM, Merrill JP, Miller BF, Thorn GW. Experiences with renal homotransplantation in the human: report of nine cases. J Clin Invest 1955;34:327-82.
13. Cook DJ, Graver B, Terasaki PI. ABO incompatibility in cadaver donor kidney allografts. Transplant Proc 1987;19:4549-52.
14. Starzl TE, Marchioro TL, Holmes JH, et al. Renal homografts in patients with major donor-recipient blood group incompatibilities. Surgery 1964;55:195-200.
15. Alexandre GP, Squifflet JP, De Bruyère M, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987;19:4538-42.
16. Tanabe K. Japanese experience of ABO-incompatible living kidney transplantation. Transplantation 2007;84(Suppl 12):S4-7.
17. Bier M, Beavers CD, Merriman WG, Merkel FK, Eiseman B, Starzl TZ. Selective plasmapheresis in dogs for delay of heterograft response. Trans Am Soc Artif Intern Organs 1970;16:325-33.
18. Bensinger WI, Buckner CD, Thomas ED, Clift RA. ABOincompatible marrow transplants. Transplantation 1982;33:427-9.
19. Slapak M, Naik RB, Lee HA. Renal transplant in a patient with major donor-recipient blood group incompatibility: reversal of acute rejection by the use of modified plasmapheresis. Transplantation 1981;31:4-7.
20. Garonzik Wang JM, Montgomery RA, Kucirka LM, Berger JC, Warren DS, Segev DL. Incompatible live-donor kidney transplantation in the United States: results of a national survey. Clin J Am Soc Nephrol 2011;6:2041-6.
21. Ichimaru N, Takahara S. Japan's experience with living-donor kidney transplantation across ABO barriers. Nat Clin Pract Nephrol 2008;4:682-92.
22. Tobian AA, Shirey RS, Montgomery RA, Ness PM, King KE. The critical role of plasmapheresis in ABO-incompatible renal transplantation. Transfusion 2008;48:2453-60.
23. Tanabe K. Double-filtration plasmapheresis. Transplantation 2007;84(Suppl 12):S30-2.
24. Bensinger WI, Buckner CD, Williams B, Clift RA. Immune adsorption of anti-A and anti-B antibodies. Prog Clin Biol Res 1982;88:295-300.
25. Bensinger WI, Buckner CD, Baker DA, Clift RA, Thomas ED. Removal of specific antibody in vivo by whole blood immunoadsorption: preliminary results in dogs. J Clin Apher 1982;1:2-5.
26. Schneider KM. Plasmapheresis and immunoadsorption: different techniques and their current role in medical therapy. Kidney Int Suppl 1998;64:S61-5.
27. Habicht A, Bröker V, Blume C, et al. Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience. Nephrol Dial Transplant 2011 [Epub ahead of print].
28. Tydén G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigenspecific immunoadsorption and rituximab. Transplantation 2003;76:730-1.
29. Wilpert J, Fischer KG, Pisarski P, et al. Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis. Nephrol Dial Transplant 2010;25:3778-86.
30. Schwenger V, Morath C. Immunoadsorption in nephrology and kidney transplantation. Nephrol Dial Transplant 2010;25:2407-13.
31. Shatney CH. Complications of splenectomy. Acta Anaesthesiol Belg 1987;38:333-9.
32. Tobian AA, Shirey RS, Montgomery RA, Ness PM, King KE. The critical role of plasmapheresis in ABO-incompatible renal transplantation. Transfusion 2008;48:2453-60.
33. Montgomery RA, Cooper M, Kraus E, et al. Renal transplantation at the Johns Hopkins Comprehensive Transplant Center. Clin Transpl 2003:199-213.
34. Takahashi K. Accommodation in ABO-incompatible kidney transplantation: why do kidney grafts survive? Transplant Proc 2004;36(Suppl 2):193S-6S.
35. Setoguchi K, Ishida H, Shimmura H, et al. Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation. Am J Transplant 2008;8:86-94.
36. Tanabe M, Shimazu M, Wakabayashi G, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2002;73:1959-61.
37. Saliba F, Ichaï P, Azoulay D, et al. Successful long-term outcome of ABO-incompatible liver transplantation using antigen-specific immunoadsorption columns. Ther Apher Dial 2010;14:116-23.
38. Strüber M, Warnecke G, Hafer C, et al. Intentional ABOincompatible lung transplantation. Am J Transplant 2008;8: 2476-8.
39. Valli PV, Puga Yung G, Fehr T, et al. Changes of circulating antibody levels induced by ABO antibody adsorption for ABO-incompatible kidney transplantation. Am J Transplant 2009;9:1072-80.
40. Genberg H, Kumlien G, Wennberg L, Berg U, Tydén G. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation 2008;85:1745-54.